https://www.selleckchem.com/products/mcc950-sodium-salt.html an Xiao, Xue-Qi Li, Shu-Hua Sun, Shi-Xing Liu, Yung-Jen Yang, Dong (Roman) Xu. Originally published in JMIR mHealth and uHealth (http//mhealth.jmir.org), 09.04.2020.BACKGROUND The benefits of electronic patient reported outcomes (PRO) questionnaires have been demonstrated in many settings, including in hospitals and patient homes. However, it remains to be investigated how melanoma patients and their treating clinicians experience the electronic self-reporting of side effects and the derived communication. OBJECTIVE The primary objective of this study was to examine patients' and clinicians' experiences with an eHealth intervention for weekly monitoring of side effects during treatment with immunotherapy. METHODS An eHealth intervention based on questions from the PRO-Common Terminology Criteria for Adverse Events (CTCAE) library was used and tested in a randomized clinical trial with patients receiving immunotherapy for malignant melanoma and clinicians at a university hospital in Denmark. On a weekly basis, patients reported their symptoms from home during the treatment via a provided tablet. The electronic patient reports were available to clinicians in the outpatientt the reporting did not lead to increased contact with the department. CONCLUSIONS Overall, satisfaction with the eHealth intervention was high among patients and their treating clinicians. The tool was easy to use and contributed to greater symptom awareness and patient involvement. Thus, in terms of patient and clinician satisfaction with the tool, it makes sense to continue using the tool beyond the project period. TRIAL REGISTRATION ClinicalTrials.gov NCT03073031; https//tinyurl.com/tjx3gtu. ©Lærke K Tolstrup, Helle Pappot, Lars Bastholt, Ann-Dorthe Zwisler, Karin B Dieperink. Originally published in the Journal of Medical Internet Research (http//www.jmir.org), 09.04.2020.BACKGROUND Pregnancy complications in combination with postpartu